CD163 and non-small cell lung carcinoma: This part of data showed that MDSC was a more sensitive marker than CD68+CD163+M2-like macrophage for NSCLC diagnosis but CD68+CD163+M2-like macrophage could predict preferably whether the NSCLC patients have received radiotherapy.